Literature DB >> 17331042

Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to AR.

Alaka Deshpande1, Valérie Jauvin, Noel Magnin, Patricia Pinson, Muriel Faure, Bernard Masquelier, Valérie Aurillac-Lavignolle, Hervé J Fleury.   

Abstract

We present here the first data available on resistance to nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) in India. In these subtype C isolates, we have observed most of the mutations noted in reverse transcriptase (RT) for subtype B with some additional substitutions (at positions 98, 203, 208, and 221) that will warrant attention in the algorithms used.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17331042     DOI： 10.1089/aid.2006.0183

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  20 in total

1.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

Authors:  Maria L Ekstrand; Anita Shet; Sara Chandy; Girija Singh; Ranjani Shamsundar; Vidya Madhavan; Shanmugam Saravanan; Elsa Heylen; Nagalingeswaran Kumarasamy
Journal:  Int Health       Date:  2011-03       Impact factor: 2.473

2.  Phenotypic analysis of HIV-1 genotypic drug-resistant isolates from China, using a single-cycle system.

Authors:  Zheng Jia; Sihong Xu; Jianhui Nie; Jingyun Li; Ping Zhong; Wenbo Wang; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

3.  Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.

Authors:  Maria Mercedes Santoro; Claudia Alteri; Luigi Ronga; Philippe Flandre; Lavinia Fabeni; Fabio Mercurio; Roberta D'Arrigo; Caterina Gori; Guido Palamara; Ada Bertoli; Federica Forbici; Romina Salpini; Evangelo Boumis; Valerio Tozzi; Ubaldo Visco-Comandini; Mauro Zaccarelli; Margriet Van Houtte; Theresa Pattery; Pasquale Narciso; Andrea Antinori; Francesca Ceccherini-Silberstein; Carlo Federico Perno
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-18       Impact factor: 2.205

Review 4.  Systematic review of HIV drug resistance in Southeast Asia.

Authors:  Andrew B Trotter; Steven Y Hong; Padmini Srikantiah; Iyanthi Abeyewickreme; Silvia Bertagnolio; Michael R Jordan
Journal:  AIDS Rev       Date:  2013 Jul-Sep       Impact factor: 2.500

5.  Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.

Authors:  Nitin K Hingankar; Smita R Thorat; Alaka Deshpande; S Rajasekaran; C Chandrasekar; Suria Kumar; Padmini Srikantiah; Devidas N Chaturbhuj; Sharda R Datkar; Pravin S Deshmukh; Smita S Kulkarni; Suvarna Sane; D C S Reddy; Renu Garg; Michael R Jordan; Sandhya Kabra; Srikanth P Tripathy; Ramesh S Paranjape
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

6.  Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.

Authors:  Ujjwal Neogi; Anita Shet; Ranjani Shamsundar; Maria L Ekstrand
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

7.  Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.

Authors:  Shanmugam Saravanan; Madhavan Vidya; Pachamuthu Balakrishnan; Rami Kantor; Sunil S Solomon; David Katzenstein; Nagalingeswaran Kumarasamy; Tokugha Yeptomi; Sathasivam Sivamalar; Samara Rifkin; Kenneth H Mayer; Suniti Solomon
Journal:  Clin Infect Dis       Date:  2012-02-09       Impact factor: 9.079

8.  Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).

Authors:  Jorge L Martinez-Cajas; Nitika P Pai; Marina B Klein; Mark A Wainberg
Journal:  J Int AIDS Soc       Date:  2009-06-30       Impact factor: 5.396

9.  One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India.

Authors:  Amita Gupta; Dattaray G Saple; Girish Nadkarni; Bijal Shah; Satish Vaidya; Nitin Hingankar; Devidas Chaturbhuj; Praveen Deshmukh; Louise Walshe; Sarah E Hudelson; Maria James; Ramesh S Paranjape; Susan H Eshleman; Srikanth Tripathy
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

10.  Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India.

Authors:  Madhavan Vidya; Shanmugam Saravanan; Shanmugasundaram Uma; Nagalingeswaran Kumarasamy; Solomon S Sunil; Rami Kantor; David Katzenstein; Bharat Ramratnam; Kenneth H Mayer; Solomon Suniti; Pachamuthu Balakrishnan
Journal:  Antivir Ther       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.